Characterization of microsomal glutathione S-transferases MGST1, MGST2, and MGST3 in cynomolgus macaque
Vallon, V., Blantz, R
NICE guidance (NG28) recommends: HbA1c monitoring every 36 months until stable, then 6-monthly Renal function tests at least annually (more frequently if pre-existing kidney disease) Weight and BMI tracking to assess treatment response Blood pressure monitoring , as weight loss may allow reduction in antihypertensive medications Appropriate retinopathy screening for patients with diabetes, particularly those with pre-existing retinopathy taking semaglutide Communication with your healthcare team is vital
Woniak A, Drewa G, Krzyzyska-Maliniowska E, Czajkowski R, Protas-Drozd F, et al
Because of this difference, GLP-1 agonists are often preferred when weight loss is a primary goal in diabetes management
Coordinate multidisciplinary care among endocrinologists, obstetricians, and reproductive specialists to optimize timing of therapy and transition